These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 7692400)

  • 1. A circular trans-acting hepatitis delta virus ribozyme.
    Puttaraju M; Perrotta AT; Been MD
    Nucleic Acids Res; 1993 Sep; 21(18):4253-8. PubMed ID: 7692400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans cleavage of RNA substrates by an HDV-derived ribozyme.
    Lescure F; Blumenfeld M; Thill G; Vasseur M; Tanner NK
    Prog Clin Biol Res; 1993; 382():99-108. PubMed ID: 8502721
    [No Abstract]   [Full Text] [Related]  

  • 4. Mimicry of the hepatitis delta virus replication cycle mediated by synthetic circular oligodeoxynucleotides.
    Diegelman AM; Kool ET
    Chem Biol; 1999 Aug; 6(8):569-76. PubMed ID: 10421762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes.
    Wadkins TS; Perrotta AT; Ferré-D'Amaré AR; Doudna JA; Been MD
    RNA; 1999 Jun; 5(6):720-7. PubMed ID: 10376872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constructing an efficient trans-acting genomic HDV ribozyme.
    Kawakami J; Yuda K; Suh YA; Kumar PK; Nishikawa F; Maeda H; Taira K; Ohtsuka E; Nishikawa S
    FEBS Lett; 1996 Sep; 394(2):132-6. PubMed ID: 8843150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.
    Jeng KS; Daniel A; Lai MM
    J Virol; 1996 Apr; 70(4):2403-10. PubMed ID: 8642668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of circular permutation on the cis-cleavage reaction of a hepatitis delta virus ribozyme: application to trans-acting ribozyme design.
    Lai YC; Lee JY; Liu HJ; Lin JY; Wu HN
    Biochemistry; 1996 Jan; 35(1):124-31. PubMed ID: 8555165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation on activities of hammerhead ribozyme embedded in genomic RNA of hepatitis delta virus].
    Li XJ; Kuang ES; Dai W; Yang FH; Wang M; Wang HS; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):12-5. PubMed ID: 16201462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribozyme cleavage of a 2,5-phosphodiester linkage: mechanism and a restricted divalent metal-ion requirement.
    Shih IH; Been MD
    RNA; 1999 Sep; 5(9):1140-8. PubMed ID: 10496215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection in vitro of trans-acting genomic human hepatitis delta virus (HDV) ribozymes.
    Nishikawa F; Kawakami J; Chiba A; Shirai M; Kumar PK; Nishikawa S
    Eur J Biochem; 1996 May; 237(3):712-8. PubMed ID: 8647117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energetic contribution of non-essential 5' sequence to catalysis in a hepatitis delta virus ribozyme.
    Shih Ih ; Been MD
    EMBO J; 2001 Sep; 20(17):4884-91. PubMed ID: 11532952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta ribozyme has the ability to cleave in transan mRNA.
    Roy G; Ananvoranich S; Perreault JP
    Nucleic Acids Res; 1999 Feb; 27(4):942-8. PubMed ID: 9927724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local conformational changes in the catalytic core of the trans-acting hepatitis delta virus ribozyme accompany catalysis.
    Harris DA; Rueda D; Walter NG
    Biochemistry; 2002 Oct; 41(40):12051-61. PubMed ID: 12356305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic core structure of the trans-acting HDV ribozyme is subtly influenced by sequence variation outside the core.
    Gondert ME; Tinsley RA; Rueda D; Walter NG
    Biochemistry; 2006 Jun; 45(24):7563-73. PubMed ID: 16768452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A toggle duplex in hepatitis delta virus self-cleaving RNA that stabilizes an inactive and a salt-dependent pro-active ribozyme conformation.
    Perrotta AT; Been MD
    J Mol Biol; 1998 Jun; 279(2):361-73. PubMed ID: 9642043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-ribozyme sequences enhance self-cleavage of ribozymes derived from Hepatitis delta virus.
    Belinsky MG; Dinter-Gottlieb G
    Nucleic Acids Res; 1991 Feb; 19(3):559-64. PubMed ID: 2011528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular ribozymes generated in Escherichia coli using group I self-splicing permuted intron-exon sequences.
    Puttaraju M; Been MD
    J Biol Chem; 1996 Oct; 271(42):26081-7. PubMed ID: 8824250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic Parameters of trans Scission by Extended HDV-like Ribozymes and the Prospect for the Discovery of Genomic trans-Cleaving RNAs.
    Webb CT; Lupták A
    Biochemistry; 2018 Mar; 57(9):1440-1450. PubMed ID: 29388767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme.
    Harris DA; Tinsley RA; Walter NG
    J Mol Biol; 2004 Aug; 341(2):389-403. PubMed ID: 15276831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.